Below are some resources you may find useful:
More information on Mysimba can be found in your Mysimba Package Leaflet
How to Prepare for a Medical Consultation – Irish Coalition for People Living with Obesity (ICPO)
Mode of Action Video
Patient Information Booklet
IE-MYS-221(1), MYS-0454-001 01/26 DOP:January 2026
The information on this website is intended for patients who have been prescribed Mysimba who reside in Ireland and Malta only.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Patients who reside in Malta are asked to report any side effects or suspected adverse events to the Malta Medicines Authority via http://medicinesauthority.gov.mt/adrportal or Vivian Corporation Ltd. via pv@viviancorp.com or +356 22588600.
Adverse events should also be reported to Orexigen : +356 800 62176 or Currax.MI@primevigilance.com
Patients who reside in Ireland are asked to report any suspected adverse events to: HPRA Pharmacovigilance via www.hpra.ie;
Adverse events should also be reported to Orexigen: +353 1800 849 099 or Currax.Ml@primevigilance.com.